Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Ginkgo Bioworks Holdings Inc DNA

Alternate Symbol(s):  DNABW

Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NYSE:DNA)

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results

PR Newswire February 25, 2025

Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab

PR Newswire February 21, 2025

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care

PR Newswire February 20, 2025

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation

PR Newswire February 18, 2025

Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series

PR Newswire February 6, 2025

Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC)

PR Newswire January 23, 2025

Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors

PR Newswire January 13, 2025

Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

PR Newswire January 9, 2025

Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program

PR Newswire December 17, 2024

Opinion & Analysis (NYSE:DNA)

No current opinion is available.

Bullboard Posts (NYSE:DNA)

Ginkgo Bioworks integrates Callisto for difficult-to-automat

NEWS: $DNA Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput labGinkgo Bioworks...
whytestocks - February 21, 2025

Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now?

Just In: $DNA Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now?2024-08-15 05:27:00 ET To say the past year has been rough for...
whytestocks - August 15, 2024

Worst investment!

Now I understood that Cathie wood is a pure gambler.... she ended her gambling in DNA and sold everything with huge loss. So the lesson...
Paray99 - July 10, 2024

AARK.

Should have been the above Ticker.  
Lookingforclues - April 25, 2024

DNA

Is this Company going anywhere? ASRK has invested heavily. Thoughts please.  Ty.
Lookingforclues - April 25, 2024

Ginkgo Bioworks Announces Participation in the 44th Annual T

JUST IN: $DNA Ginkgo Bioworks Announces Participation in the 44th Annual TD Cowen Health Care ConferenceGinkgo Bioworks Announces...
whytestocks - February 27, 2024